Cargando…
Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis
BACKGROUND AND AIM: Ursodeoxycholic acid (UDCA) is the standard treatment for primary biliary cirrhosis (PBC), but not all cases respond well. Evidence has shown that combination therapy of UDCA with bezafibrate significantly improved liver function. A meta-analysis was performed to assess the effic...
Autores principales: | Yin, Qin, Li, Jingjing, Xia, Yujing, Zhang, Rong, Wang, Jianrong, Lu, Wenxia, Zhou, Yuqing, Zheng, Yuanyuan, Abudumijiti, Huerxidan, Chen, Rongxia, Chen, Kan, Li, Sainan, Liu, Tong, Wang, Fan, Lu, Jie, Zhou, Yingqun, Guo, Chuanyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599574/ https://www.ncbi.nlm.nih.gov/pubmed/26491252 http://dx.doi.org/10.2147/DDDT.S92041 |
Ejemplares similares
-
Inhibitive effects of 15-deoxy-Δ(12),(14)-prostaglandin J(2) on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis
por: Chen, Kan, et al.
Publicado: (2015) -
Astaxanthin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells via Inhibition of Nf-Κb P65 and Wnt/Β-Catenin in Vitro
por: Li, Jingjing, et al.
Publicado: (2015) -
Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis
por: Zhang, Yan, et al.
Publicado: (2015) -
Combination therapy of ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome: a meta-analysis
por: Zhang, Huawei, et al.
Publicado: (2015) -
By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice
por: Dai, Weiqi, et al.
Publicado: (2015)